Paul, Re TA advice on Vivus. Your data appear correct, however I am not
an expert,or knowledgable in TA; I use my broker for that. Essentially
my investment is based on tape watching, FA, market timing and a fly
by the seat of your pants/home grown investing (gg).Thus I am very
reluctant to reccommend anything to anybody.I just tell people what
I do, but don't reccommend that they follow my advice because if I happen
at some time to decide to get in or out of a stock, I cannot be responsible
to locate and advise everybody else of my move!!!! gg.
We have however on this thread owr own Technical Analysts who I suspect
are as good as anybody else's thread <gg> and to whom I would like to
refer your question if I may.
If anybody on this thread feels qualified to answer Paul, please do so.
Pesonally I feel tha the big resistance point is 33.5.If we get past
that, next stop is likely to be 42 but it will be brief because of the
new factory coming on line in Dec which will solve the main problem that
Vivus faces: not enough Muse to fill demand.Production will be up 500%
new agressive marketing will come on line to managed care and sales
will skyrocket. I also expect the FDA to clear Vivus, at least on
the " hardship " basis <gg>: there is no othercoservative, ie non-invasive,
therapy for ED in the world.
Also remember, MOST PHYSICIANS, let alone patients, STILL DON'T KNOW
ABOUT VIVUS/MUSE!!!!!
TA
PS: We had a good time yesterday in INTC thread didn't we? Can't
wait for Mon. <g>. |
